Diseases
One of our primary goals at NeuroCure is to see the insights of basic science translated into clinical application. Through an integrative framework, we support the facilitation and development of cutting-edge therapies and new diagnostic approaches and technologies. By dovetailing outstanding basic and clinical research with expertise in conducting clinical studies, NeuroCure endeavors to find and improve treatments for a wide range of neurological diseases such as stroke, multiple sclerosis, Alzheimer's disease and dementia, and psychiatric disorders like autism, depression, schizophrenia, and addiction.
The Neuroscience (initially NeuroCure) Clinical Research Center (NCRC) was founded in 2008 to provide patients with the fastest possible access to new therapeutic and diagnostic options. Today, NCRC researchers are active in areas of cerebrovascular, neuroinflammatory and neurodegenerative diseases, as well as mental illnesses, and disturbances in functional network structures. Clinical studies targeting the following diseases are also currently being carried out with support of the NCRC:
- Stroke
- Myasthenia gravis
- Polyneuropathies (e.g. CIDP)
- Multiple sclerosis
- Neuromyelitis optica spectrum disorders (NMOSD)
- Alzheimer’s disease and dementia
- Epilepsy
- Developmental disturbances of the nervous system
- Addictive disorders
- Depression
- Schizophrenia
For more information, please visit our Clinical Research Center.